期刊文献+

丽水地区2017年细菌耐药监测分析 被引量:1

Monitoring and analysis of antimicrobial resistance in Lishui, 2017
原文传递
导出
摘要 目的了解丽水地区2017年临床分离菌株对常用抗菌药物的耐药情况。方法对丽水地区12所医院临床分离菌采用K-B法或自动化仪器法进行药敏试验,按CLSI 2017年标准判断结果,采用WHONET 5.6软件进行统计分析。结果本次监测共分离细菌15463株;排名前5位的细菌依次为大肠埃希菌、肺炎克雷伯菌、金黄色葡萄球菌、铜绿假单胞菌、鲍曼不动杆菌;耐甲氧西林金黄色葡萄球菌(MRSA)检出率为31.0%;未发现对万古霉素耐药的金黄色葡萄球菌;大肠埃希菌和肺炎克雷伯菌中ESBL检出率为46.4%和29.0%;肺炎克雷伯菌近年来的分离率及耐药率呈稳步上升趋势;非发酵菌对碳青霉烯类药物的耐药率较高。结论临床分离菌对常见抗菌药物的耐药较为严重,尤其是耐碳青霉烯类的肺炎克雷伯菌;在继续做好细菌耐药监测工作的同时加强微生物实验室与临床的沟通与合作,发挥耐药监测的指导作用,共同遏制耐药菌的传播。 Objective To investigate the drug resistance of the clinical isolates from Lishui area in 2017.Methods Twelve hospitals were involved in this program.Antimicrobial susceptibility testing was carried out according to Kirby-Bauer method or automated systems.Results were analyzed by software WHONET 5.6 according to CLSI 2017.Results A total of 15463 clinical isolates were collected;The top 5 isolates were Escherichia coli,Klebsiella pneumoniae,Staphylococcus aureus,Pseudomonas aeruginosa and Acinetobacter baumanni;The prevalence of methicillin-resistant Staphylococcus aureus(MRSA)was 31.0%;No S.aureus strains were found resistant to vancomycin;ESBLs-producing strains accounted for 46.4%in E.coli and 29.0%in K.pneumoniae;The prevalence and resistance rates of K.pneumoniae were ascending.recently;The resistance rate of non-fermenting bacteria to carbapenems was generally high.Conclusion Bacterial resistance is still severe,especially the CRKP;It is necessary to strengthen the communication and cooperation of laboratories and clinicians,and the surveillance data should be used to prevent the spread of drug-resistant bacteria.
作者 吴宁俊 刘五高 林德 WU Ning-jun;LIU Wu-gao;LIN De(Clinical Laboratory,Lishui City People's Hospital,Lishui,Zhejiang 323000,China)
出处 《中国卫生检验杂志》 CAS 2019年第22期2775-2778,2781,共5页 Chinese Journal of Health Laboratory Technology
基金 浙江省自然科学基金(Y12H190008)
关键词 丽水市 耐药监测 抗菌药物 药敏试验 Lishui Bacterial resistance surveillance Antibiotics Antimicrobial susceptibility testing
  • 相关文献

参考文献8

二级参考文献65

  • 1谈华,邵海枫,王锦娜,王卫萍,李珍大.舒巴坦单剂及舒巴坦与第三代头孢菌素联合对鲍曼不动杆菌的体外抗菌作用比较[J].中国抗生素杂志,2006,31(8):488-491. 被引量:39
  • 2Levy SB.Active efflux,a common mechanism for biocide andantibiotic resistance[J].Syrup Ser Soc Appl Microbiol,2002(31):655-715.
  • 3Denny B,West P.Panigrahi D.Effects of permeabilizers onanfimicrobial susceptibility of Stenotrophomonas maltophiliaand Acinetobacter spp[J].Microbiol Immunol Infect,2003,36(1):72-76.
  • 4Koch S,Hufnagel M,Huebner J.Treatment and preventionof enterococcal infections alternative and experimental approa-ches[J].Expert Opin Biol Ther,2004,4(9):1519-1531.
  • 5Yong D,Toleman MA,Giske CG. Characterization of a new metallo-beta-lactamase gene,bla(NDM-1),and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[J].{H}Antimicrobial Agents and Chemotherapy,2009.5046-5054.
  • 6Kumarasamy KK,Toleman MA,Walsh TR. Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological,and epidemiological study[J].{H}LANCET INFECTIOUS DISEASES,2010.597-602.
  • 7Ho PL,Lo WU,Yeung MK. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong[J].PLoS One,2011.e17989.
  • 8Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing;Twenty-Second Informational Supplement.M100-S22 Vol.32 No.3[J].Wayne PA 19087 USA CLSI,2012.
  • 9Dongeun Yong,Kyungwon Lee,Jong Hwa Yum. Imipenem-EDTA Disk Method for Differentiation of Metallo-Lactamase-Producing Clinical Isolates of Pseudomonas spp and Acinetobacter spp[J].Journal of Clinical Microbiology,2002.37983801.
  • 10中华人民共和国国家卫生部.产NDM-1泛耐药肠杆菌科细菌感染诊疗指南(试行版)[J],2010.

共引文献491

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部